$0.000001
At close: Sep 17, 12:22 PM EDT
Comments
Loading...
Huaizhong Health Gr Analyst Ratings and Price Targets | OTC:ADAD | Benzinga
Huaizhong Health Gr Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Huaizhong Health Gr Corp from these most-recent analyst ratings.
Analyst Ratings for Huaizhong Health Gr
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Huaizhong Health Gr (ADAD) stock?
There is no price target for Huaizhong Health Gr
What is the most recent analyst rating for Huaizhong Health Gr (ADAD)?
There is no analyst for Huaizhong Health Gr
When was the last upgrade for Huaizhong Health Gr (ADAD)?
There is no last upgrade for Huaizhong Health Gr
When was the last downgrade for Huaizhong Health Gr (ADAD)?
There is no last downgrade for Huaizhong Health Gr.
When is the next analyst rating going to be posted or updated for Huaizhong Health Gr (ADAD)?
There is no next analyst rating for Huaizhong Health Gr.
Is the Analyst Rating Huaizhong Health Gr (ADAD) correct?
There is no next analyst rating for Huaizhong Health Gr.
Browse analyst ratings and price targets on all stocks.
